Immunome, Inc. - Common Stock (NQ:IMNM)

18.35 +0.06 (+0.33%)

Delayed Quote Updated: 11:08 AM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Immunome, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

62 Biggest Movers From Yesterday ↗

July 21, 2021

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...

Via Benzinga

Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher ↗

July 20, 2021

Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has...

Via Benzinga

Topics Stocks

Why Immunome's Stock Is Soaring Today ↗

July 20, 2021

Immunome Inc (NASDAQ:IMNM) is surging Tuesday morning afte...

Via Benzinga

Thinking About Buying Stock In Immunome, Axsome Or Etsy? ↗

April 26, 2021

Immunome Inc (NASDAQ:IMNM) shares are trading higher by 9.25% by $32.28 after the ...

Via Benzinga

Dow Rises 500 Points as Rally Gains Momentum ↗

July 20, 2021

Stocks are on a tear midday, as investors shake off delta variant fears and buy the dip in the wake of yesterday's selloff.

Via Talk Markets

Topics Stocks

34 Stocks Moving In Tuesday's Mid-Day Session ↗

July 20, 2021

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA...

Via Benzinga

IMNM Stock: The Covid Treatment News That Has Immunome Soaring Today ↗

July 20, 2021

IMNM stock is having a great day today. The company is preparing to move forward with expedited testing for its delta variant treatment.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Higher; Philip Morris Posts Mixed Q2 Results ↗

July 20, 2021

Following the market opening Tuesday, the Dow traded up 1.32% to 34,409.28 while the NASDAQ rose 0.48% to 14,343.85. The S&P also rose, gaining 0.91% to 4,297.39. The U.S. has...

Via Benzinga

Topics Stocks

Immunome Stock Jumps As COVID-19 Antibody Shows Preclinical Neutralizing Activity Against Delta Variant ↗

July 20, 2021

Immunome Inc (NASDAQ: IMNM) has announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against COVI-19 Delta variant...

Via Benzinga

Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing

July 20, 2021

From Immunome, Inc.

Via Business Wire

Immunome to Present at the Ladenburg Thalmann 2021 Healthcare Conference

July 06, 2021

From Immunome, Inc.

Via Business Wire

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

Immunome Appoints Andrew Badley, M.D., to COVID-19 Advisory Board

June 30, 2021

From Immunome, Inc.

Via Business Wire

Immunome Appoints Franklyn G. Prendergast, M.D., Ph.D., to Board of Directors

June 17, 2021

From Immunome, Inc.

Via Business Wire

Immunome to Present at the Jefferies Virtual Healthcare Conference

May 27, 2021

From Immunome, Inc.

Via Business Wire

Immunome Secures Additional $4.3M Funding From DoD To Develop COVID-19 Antibody Cocktail ↗

May 20, 2021

Immunome Inc (NASDAQ: IMNM) has secured additional funding of $4.3 million from the Department of Defense (DoD) for the development of an antibody cocktail (IMM-...

Via Benzinga

60 Biggest Movers From Yesterday ↗

May 28, 2021

Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related...

Via Benzinga

Immunome Announces Additional $4.3 Million Award by DOD following Positive Preclinical Testing Results on COVID-19 Variants of Concern

May 20, 2021

From Immunome, Inc.

Via Business Wire

Immunome Reports First Quarter 2021 Financial Results

May 12, 2021

From Immunome, Inc.

Via Business Wire

Immunome Raises $27M Via Private Equity Placement At 9% ↗

April 26, 2021

In addition to encouraging preclinical data from the COVID-19 antibody cocktail announced today, Immunome Inc (NASDAQ: IMNM) has entered into a...

Via Benzinga

Immunome's Stock Jumps On Its Antibody Cocktail Neutralizing Multiple COVID-19 Variants In Animal Studies ↗

April 26, 2021

Immunome Inc (NASDAQ: IMNM) has announced antibody selection for its IMM-BCP-01 antibody cocktail and shared preclinical data showing that IMM-BCP-01 is...

Via Benzinga

Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing; Progressing Towards IND Filing

April 26, 2021

From Immunome, Inc.

Via Business Wire

Immunome Announces $27 Million Private Placement

April 26, 2021

From Immunome, Inc.

Via Business Wire

Immunome Appoints Corleen Roche as Chief Financial Officer

April 20, 2021

From Immunome

Via Business Wire

55 Biggest Movers From Yesterday ↗

April 20, 2021

Gainers Marlin Business Services Corp. (NASDAQ: MRLN) shares surged 50.7% to close at $21.46 on Monday after the company enters into a definitive agreement to be acquired by...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.